Advanced search
Publication Cover
OncoImmunology Volume 13, 2024 - Issue 1
Submit an article Journal homepage
897
Views
0
CrossRef citations to date
0
Altmetric
Original Research

HIF2A mediates lineage transition to aggressive phenotype of cancer-associated fibroblasts in lung cancer brain metastasis

Muyuan Youa Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;b National Center for Neurological Disorders, Shanghai, China;c Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China;d Neurosurgical Institute of Fudan University, Shanghai, China;e Shanghai Clinical Medical Center of Neurosurgery, Shanghai, ChinaView further author information
,
Minjie Fua Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;b National Center for Neurological Disorders, Shanghai, China;c Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China;d Neurosurgical Institute of Fudan University, Shanghai, China;e Shanghai Clinical Medical Center of Neurosurgery, Shanghai, ChinaView further author information
,
Zhewei Shena Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;b National Center for Neurological Disorders, Shanghai, China;c Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China;d Neurosurgical Institute of Fudan University, Shanghai, China;e Shanghai Clinical Medical Center of Neurosurgery, Shanghai, ChinaView further author information
,
Yuan Fenga Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;b National Center for Neurological Disorders, Shanghai, China;c Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China;d Neurosurgical Institute of Fudan University, Shanghai, China;e Shanghai Clinical Medical Center of Neurosurgery, Shanghai, ChinaView further author information
,
Licheng Zhanga Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;b National Center for Neurological Disorders, Shanghai, China;c Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China;d Neurosurgical Institute of Fudan University, Shanghai, China;e Shanghai Clinical Medical Center of Neurosurgery, Shanghai, ChinaView further author information
,
Xianmin Zhuf Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai, ChinaView further author information
,
Zhengping Zhuangg Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAView further author information
,
Ying Maoa Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;b National Center for Neurological Disorders, Shanghai, China;c Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China;d Neurosurgical Institute of Fudan University, Shanghai, China;e Shanghai Clinical Medical Center of Neurosurgery, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Wei Huaa Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;b National Center for Neurological Disorders, Shanghai, China;c Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Shanghai, China;d Neurosurgical Institute of Fudan University, Shanghai, China;e Shanghai Clinical Medical Center of Neurosurgery, Shanghai, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2356942 | Received 16 Mar 2024, Accepted 13 May 2024, Published online: 20 May 2024

References

  • Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US. JAMA Oncol. 2021;7(12):1824–14. doi:10.1001/jamaoncol.2021.4932.
  • Riihimäki M, Hemminki A, Fallah M, Thomsen H, Sundquist K, Sundquist J, Hemminki K. Metastatic sites and survival in lung cancer. Lung Cancer. 2014 Oct;86(1):78–84. doi:10.1016/j.lungcan.2014.07.020.
  • Castrucci WA, Knisely JP. An update on the treatment of CNS metastases in small cell lung cancer. Cancer J. 2008;14(3):138–146. doi:10.1097/PPO.0b013e318172d6e1.
  • Hao Y, Li G. Risk and prognostic factors of brain metastasis in lung cancer patients: a surveillance, epidemiology, and end results population‑based cohort study. Eur J Cancer Prev. 2023;32(5):498–511. doi:10.1097/cej.0000000000000790.
  • Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, D’Amico TA, DeCamp MM, Dilling TJ, Dobelbower M. et al. Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2017;15(4):504–535. doi:10.6004/jnccn.2017.0050.
  • Chae YK, Arya A, Iams W, Cruz MR, Chandra S, Choi J, Giles F. Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC). J Immunother Cancer. 2018;6(1):39. doi:10.1186/s40425-018-0349-3.
  • Eguren-Santamaria I, Sanmamed MF, Goldberg SB, Kluger HM, Idoate MA, Lu BY, Corral J, Schalper KA, Herbst RS, Gil-Bazo I. et al. PD-1/PD-L1 blockers in NSCLC brain metastases: Challenging paradigms and clinical practice. Clin Cancer Res. 2020;26(16):4186–4197. doi:10.1158/1078-0432.Ccr-20-0798.
  • Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, Lee J-I, Suh Y-L, Ku BM, Eum HH. et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285. doi:10.1038/s41467-020-16164-1.
  • Wang Z, Wang Y, Chang M, Wang Y, Liu P, Wu J, Wang G, Tang X, Hui X, Liu P. et al. Single-cell transcriptomic analyses provide insights into the cellular origins and drivers of brain metastasis from lung adenocarcinoma. Neuro Oncol. 2023;25(7):1262–1274. doi:10.1093/neuonc/noad017.
  • Batlle E, Massagué J. Transforming growth factor-β signaling in immunity and cancer. Immunity. 2019;50(4):924–940. doi:10.1016/j.immuni.2019.03.024.
  • Zhang Q, Abdo R, Iosef C, Kaneko T, Cecchini M, Han VK, Li SSC. The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. Nat Commun. 2022;13(1):5983. doi:10.1038/s41467-022-33365-y.
  • Münsterberg J, Loreth D, Brylka L, Werner S, Karbanova J, Gandrass M, Schneegans S, Besler K, Hamester F, Robador JR. et al. ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium. Neuro Oncol. 2020;22(7):955–966. doi:10.1093/neuonc/noaa028.
  • Passaro A, Jänne PA, Mok T, Peters S. Overcoming therapy resistance in EGFR-mutant lung cancer. Nat Cancer. 2021;2(4):377–391. doi:10.1038/s43018-021-00195-8.
  • Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582–598. doi:10.1038/nrc.2016.73.
  • Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437. doi:10.1038/nm.3394.
  • Sun HF, Li LD, Lao IW, Li X, Xu BJ, Cao YQ, Jin W. Single-cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastases. Clin Transl Med. 2022;12(11):e1101. doi:10.1002/ctm2.1101.
  • Luo H, Xia X, Huang LB, An H, Cao M, Kim GD, Chen H-N, Zhang W-H, Shu Y, Kong X. et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 2022;13(1):6619. doi:10.1038/s41467-022-34395-2.
  • Ma C, Yang C, Peng A, Sun T, Ji X, Mi J, Wei L, Shen S, Feng Q. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol Cancer. 2023 Oct 13;22(1):170. doi:10.1186/s12943-023-01876-x.
  • Choi YP, Lee JH, Gao MQ, Kim BG, Kang S, Kim SH, Cho NH. Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models. Int J Cancer. 2014;135(9):2024–2033. doi:10.1002/ijc.28848.
  • Chung B, Esmaeili AA, Gopalakrishna-Pillai S, Murad JP, Andersen ES, Kumar Reddy N, Srinivasan G, Armstrong B, Chu C, Kim Y. et al. Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12. NPJ Breast Cancer. 2017;3(1):6. doi:10.1038/s41523-017-0008-8.
  • Liu D, Schilling B, Liu D, Sucker A, Livingstone E, Jerby-Arnon L, Zimmer L, Gutzmer R, Satzger I, Loquai C. et al. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat Med. 2019;25(12):1916–1927. doi:10.1038/s41591-019-0654-5.
  • Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118–127. doi:10.1093/biostatistics/kxj037.
  • Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M. et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573–87.e29. doi:10.1016/j.cell.2021.04.048.
  • Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8.
  • Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141. doi:10.1016/j.xinn.2021.100141.
  • Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102.
  • Steen CB, Liu CL, Alizadeh AA, Newman AM. Profiling cell type abundance and expression in bulk tissues with CIBERSORTx. Methods Mol Biol. 2020;2117:135–157. doi:10.1007/978-1-0716-0301-7_7.
  • Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, Baglaenko Y, Brenner M, Loh P-R, Raychaudhuri S. et al. Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods. 2019;16(12):1289–1296. doi:10.1038/s41592-019-0619-0.
  • Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088. doi:10.1038/s41467-021-21246-9.
  • Qiu X, Mao Q, Tang Y, Wang L, Chawla R, Pliner HA, Trapnell C. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979–982. doi:10.1038/nmeth.4402.
  • Van de Sande B, Flerin C, Davie K, De Waegeneer M, Hulselmans G, Aibar S, Seurinck R, Saelens W, Cannoodt R, Rouchon Q. et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020;15(7):2247–2276. doi:10.1038/s41596-020-0336-2.
  • Suo S, Zhu Q, Saadatpour A, Fei L, Guo G, Yuan GC. Revealing the critical regulators of cell identity in the mouse cell atlas. Cell Rep. 2018;25(6):1436–45.e3. doi:10.1016/j.celrep.2018.10.045.
  • Lendahl U, Muhl L, Betsholtz C. Identification, discrimination and heterogeneity of fibroblasts. Nat Commun. 2022;13(1):3409. doi:10.1038/s41467-022-30633-9.
  • Luo Z, Tian M, Yang G, Tan Q, Chen Y, Li G, Zhang Q, Li Y, Wan P, Wu J. et al. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduct Target Ther. 2022;7(1):218. doi:10.1038/s41392-022-01080-1.
  • Wang R, Godet I, Yang Y, Salman S, Lu H, Lyu Y, Zuo Q, Wang Y, Zhu Y, Chen C. et al. Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. Proc Natl Acad Sci USA. 2021;118(19). doi:10.1073/pnas.2020490118.
  • Hung PF, Hong TM, Chang CC, Hung CL, Hsu YL, Chang YL, Wu C-T, Chang G-C, Chan N-L, Yu S-L. et al. Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis. J Exp Clin Cancer Res. 2019;38(1):5. doi:10.1186/s13046-018-0996-8.
  • Li L, Liang Y, Kang L, Liu Y, Gao S, Chen S, Li Y, You W, Dong Q, Hong T. et al. Transcriptional regulation of the warburg effect in cancer by SIX1. Cancer Cell. 2018;33(3):368–85.e7. doi:10.1016/j.ccell.2018.01.010.
  • Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, Sun L, Liu Y, Du Y, Guo X. et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 2023;78(4):770–782. doi:10.1016/j.jhep.2023.01.011.
  • Boelaars K, Rodriguez E, Huinen ZR, Liu C, Wang D, Springer BO, Olesek K, Goossens-Kruijssen L, van Ee T, Lindijer D. et al. Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions. Commun Biol. 2024;7(1):430. doi:10.1038/s42003-024-06087-8.
  • Bill R, Wirapati P, Messemaker M, Roh W, Zitti B, Duval F, Kiss M, Park JC, Saal TM, Hoelzl J. et al. CXCL9: SPP1 macrophage polarity identifies a network of cellular programs that control human cancers. Science. 2023;381(6657):515–524. doi:10.1126/science.ade2292.
  • Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, Ding X, Bao R, Hong L, Jia W. et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742. doi:10.1038/s41467-022-29366-6.
  • Bertero T, Oldham WM, Grasset EM, Bourget I, Boulter E, Pisano S, Hofman P, Bellvert F, Meneguzzi G, Bulavin DV. et al. Tumor-stroma mechanics coordinate amino acid availability to sustain tumor growth and malignancy. Cell Metab. 2019;29(1):124–40.e10. doi:10.1016/j.cmet.2018.09.012.
  • Wang Y, Liang Y, Xu H, Zhang X, Mao T, Cui J, Yao J, Wang Y, Jiao F, Xiao X. et al. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discov. 2021;7(1):36. doi:10.1038/s41421-021-00271-4.
  • Grout JA, Sirven P, Leader AM, Maskey S, Hector E, Puisieux I, Steffan F, Cheng E, Tung N, Maurin M. et al. Spatial positioning and matrix programs of cancer-associated fibroblasts promote t-cell exclusion in human lung tumors. Cancer Discov. 2022;12(11):2606–2625. doi:10.1158/2159-8290.Cd-21-1714.
  • Liu J, Li P, Wang L, Li M, Ge Z, Noordam L, Lieshout R, Verstegen MMA, Ma B, Su J. et al. Cancer-associated fibroblasts provide a stromal niche for liver cancer organoids that confers trophic effects and therapy resistance. Cell Mol Gastroenterol Hepatol. 2021;11(2):407–431. doi:10.1016/j.jcmgh.2020.09.003.
  • Kawakami T, Mimura I, Shoji K, Tanaka T, Nangaku M. Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes. Kidney Int Suppl. 2014;4(1):107–112. doi:10.1038/kisup.2014.20.
  • Jaśkiewicz M, Moszyńska A, Króliczewski J, Cabaj A, Bartoszewska S, Charzyńska A, Gebert M, Dąbrowski M, Collawn JF, Bartoszewski R. et al. The transition from HIF-1 to HIF-2 during prolonged hypoxia results from reactivation of PHDs and HIF1A mRNA instability. Cell Mol Biol Lett. 2022;27(1):109. doi:10.1186/s11658-022-00408-7.
  • Lee JW, Ko J, Ju C, Eltzschig HK. Hypoxia signaling in human diseases and therapeutic targets. Experimental & Molecular Medicine. 2019;51(6):1–13. doi:10.1038/s12276-019-0299-y.
  • Gao F, Yao Q, Zhu J, Chen W, Feng X, Feng B, Wu J, Pacak K, Rosenblum J, Yu J. et al. A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation. Pharmacol Res. 2023;194:106851. doi:10.1016/j.phrs.2023.106851.
  • Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K. et al. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med. 2012;367(10):922–930. doi:10.1056/NEJMoa1205119.
  • Rosenblum JS, Wang H, Dmitriev PM, Cappadona AJ, Mastorakos P, Xu C, Jha A, Edwards N, Donahue DR, Munasinghe J. et al. Developmental vascular malformations in EPAS1 gain-of-function syndrome. JCI Insight. 2021;6(5). doi:10.1172/jci.insight.144368.
  • Yu J, Shi X, Yang C, Bullova P, Hong CS, Nesvick CL, Dmitriev P, Pacak K, Zhuang Z, Cao H. et al. A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycythemia. Aging (Albany NY). 2020;12(7):5781–5791. doi:10.18632/aging.102967.
  • Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, Oudard S, Else T, Maranchie JK, Welsh SJ. et al. Belzutifan for renal cell carcinoma in von hippel–lindau disease. N Engl J Med. 2021;385(22):2036–2046. doi:10.1056/NEJMoa2103425.
  • Albiges L, Rini BI, Peltola K, De Velasco Oria GA, Burotto M, Suarez Rodriguez C, Ghatalia P, Iacovelli R, Lam ET, Verzoni E. et al. LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study. Ann Oncol. 2023;34:S1329–S30. doi:10.1016/j.annonc.2023.10.090.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.